The India Diabetes Market is experiencing robust growth as the country continues to face a rising burden of diabetes driven by urbanization, sedentary lifestyles, unhealthy dietary habits, obesity, and an aging population. Diabetes has become one of India's most significant public health challenges, increasing the demand for advanced diagnostics, innovative therapeutics, insulin delivery...

The India Diabetes Market is on the cusp of a transformative phase, with projections indicating a substantial increase from USD 6.86 billion in 2024 to USD 13.77 billion by 2035. This impressive trajectory, marked by a compound annual growth rate (CAGR) of 6.54%, is symptomatic of the urgent need to tackle the diabetes epidemic affecting millions across the nation. As India grapples with its...